Prerpints.org logo
Preprint
Article

This version is not peer-reviewed.

Antidiabetic Properties of Polyalthia longifolia: A Comprehensive In Vitro Study of Leaf and Stem Extracts

A peer-reviewed version of this preprint was published in:
Molecules 2025, 30(21), 4264. https://doi.org/10.3390/molecules30214264

Submitted:

30 September 2025

Posted:

30 September 2025

You are already at the latest version

Abstract

Polyalthia longifolia, a member of the Annonaceae family, is traditionally used for its medicinal properties, including as an antidiabetic remedy, primarily in Asia and sub-Saharan Africa. This study investigated the potential of six P. longifolia extracts in counteracting hyperglycemia and diabetes-related complications. Aqueous, ethanol, and methanol extracts from leaves and stems were evaluated for their antihyperglycemic, antiglycation, and antiradical properties using α-glucosidase, BSA, and ORAC assays, respectively. Phytochemical characterization was conducted using TPC and TFC assays, and HPLC analysis identified specific bioactive compounds, including various phenolic compounds and flavonoids (mainly baicalein). The MTT assay on the human cell line HT-29 assessed the activity of extracts on cell viability, showing slight cytotoxicity. Results demonstrated significant antidiabetic activity of the ethanol and methanol extracts from P. longifolia leaves. This study provides new insights into the potential use of P. longifolia in diabetes mellitus and supports the valorization of traditional medicinal plants.

Keywords: 
α-glucosidase inhibition
;  
Polyphenols
;  
flavonoids
;  
AGEs
;  
Traditional medicine
;  
Annonaceae
;  
ROS scavenging
;  
HPLC-DAD analysis
;  
antidiabetic activity
Subject: 
Medicine and Pharmacology  -   Pharmacology and Toxicology

1. Introduction

Diabetes mellitus (DM), a chronic metabolic disorder characterized by persistently high blood glucose levels, is a growing health concern. Projections indicate that by 2045, the global prevalence of DM will reach 783.2 million cases, a significant increase from the 537 million in 2021 [1]. Regrettably, this substantial rise is not expected to correspond with a proportional growth in healthcare expenditure. The majority of new cases are expected in developing countries with medium to low incomes, where DM-related healthcare costs are typically moderate [1]. For this reason, it is crucial to expand research on and improve knowledge about antidiabetic medicinal plants. These resources can provide more cost-effective treatment options, requiring less processing and infrastructure compared to synthetic or, moreover, biotechnological drugs, making plant-derived products particularly valuable in resource-limited conditions [2].
The genus Polyalthia includes 120 species, primarily found in Africa, Asia, and Australia. Native to southern India and Sri Lanka, P. longifolia has been subsequently introduced to various parts of Asia, and in West and Central Africa [3]. The species P. longifolia var. pendula (Sonn.) Thwaites, a member of the Annonaceae family, is a columnar tree that can reach a height of 20 meters, characterized by lanceolate leaves with curvy margins and an acuminate apex, measuring between 12 to 30 cm in length (Figure S1). P. longifolia holds a significant place in Indian traditional medicine, where it is commonly employed for several medicinal purposes including treatment of hypertension, management of intestinal parasites, regulation of glycemia, and as anti-inflammatory remedy [4,5,6]. Phytochemical investigations reported the presence of various constituents, mainly terpenes (clerodane diterpenes), tannins, polyphenols, and aporphine alkaloids [5,6,7,8,9,10].
The literature reports few investigations regarding the antidiabetic activities of P. longifolia. Firstly, Nair et al. (2007) reported the capacity of P. longifolia leaf extracts to counteract hyperglycemia in alloxan-induced diabetic rats [11]. Successively, Sivashanmugam and Chatterjee (2013) described that ethanol and chloroform leaf extracts progressively reduced fasting blood glucose levels during a 28-week treatment, with effects comparable to metformin [12]. Furthermore, the authors reported that the extracts were able to moderately reduce the activity of α-glucosidase and α-amylase enzymes in vitro [12,13]. However, the available data are limited and still require further investigation.
Hyperglycemia-induced damage is associated with various mechanisms; among these are insulin resistance, formation of radical species, and Advanced Glycation End Products (AGEs) [14]. These reactive compounds originate from non-enzymatic reactions between reducing sugars and macromolecules such as proteins, nucleic acids, or lipids. The process begins with the Maillard reaction, where an aldehyde or ketone carbonyl group of a reducing sugar (e.g., glucose, fructose, ribose) reacts with lysine and arginine amino acid residues [15]. Through various rearrangements and consequent reactions, this leads to the formation of AGEs, a heterogeneous class of irreversible compounds responsible for permanent cellular and tissue damage [16].
To evaluate the antidiabetic potential of P. longifolia, this research examined six different extracts using various solvents and plant parts. The extracts were prepared using aqueous (W), ethanol (E), and methanol (M) as solvents, derived from either leaves (L) or stems (S) of P. longifolia (PL). The resulting abbreviations are: PLLW, PLLE, and PLLM for leaf extracts, and PLSW, PLSE, and PLSM for stem extracts. Their hypoglycemic potential was evaluated with the α-glucosidase assay, while antiglycation activity was estimated using the ribose-induced BSA (Bovine Serum Albumin) assay. Antioxidant capacity was determined by the ORAC (Oxygen Radical Absorbance Capacity) assay. Phytochemical composition was characterized through the detection of TPC (Total Phenol Content) and TFC (Total Flavonoid Content), as well as HPLC-DAD analysis. Furthermore, the safety of the extracts was explored through the MTT assay, detecting the cell viability on HT-29 cells. This approach aimed to provide an in-depth understanding of P. longifolia extracts for their potential medicinal use.

2. Results

2.1. In Vitro Antidiabetic Properties

2.1.1. α-Glucosidase Inhibition

The yeast α-glucosidase assay was employed to evaluate the potential of P. longifolia extracts to inhibit the activity of the enzyme responsible for food carbohydrate digestion, which contributes to hyperglycemia in vivo. This assay serves as a model for the action of human α-glucosidase [17]. The reaction was monitored for 70 minutes under controlled conditions. Acarbose was used as positive control. Aqueous, ethanol, and methanol leaf and stem extracts were tested at concentrations ranging from 1 µg/mL to 100 µg/mL (Figure 1). Particularly, ethanol and methanol leaf extracts exhibited statistically significant inhibition at concentrations as low as 5 μg/mL (p < 0.01 and 0.05, respectively). In contrast, the aqueous leaf extract displayed a moderate inhibitory activity, only at the higher concentration of 25 μg/mL (19.55 ± 4.65%, p < 0.05). At this same concentration, both ethanolic and methanolic leaf extracts achieved near-complete enzyme inhibition (Figure 1). All stem extracts showed lower potency. The aqueous stem extract did not exhibit any inhibitory activity across all tested concentrations. The ethanol stem extract started showing significant inhibition at 25 μg/mL (15.63 ± 2.66%, p < 0.05), while the methanol stem extract only demonstrated inhibitory effects at 50 μg/mL and above. The maximum inhibition observed for 100 μg/mL P. longifolia ethanol and methanol stem extracts was 35.30 ± 2.61% and 51.25 ± 4.49%, respectively.
These findings suggest a marked difference in the α-glucosidase inhibitory effect between leaf and stem extracts of P. longifolia, with leaf extracts, particularly those obtained using ethanol and methanol as solvents, showing the most promising inhibition of enzyme activity.
The differential potency of P. longifolia extracts in inhibiting α-glucosidase activity is further proved using heatmap analysis (Figure 2). This visualization illustrates the dynamic changes in enzyme activity over a 70-minute period, at various concentrations of each extract. The heatmap provides a color-coded representation of enzyme activity, where darker (red) shades indicate higher levels of enzyme activity, while lighter (clear blue) shades represent no enzyme action or inhibition over time. The relative white color represents an intermediate level of activity between clear blue and red. This analysis corroborates the findings previously reported in Figure 1, emphasizing the superior inhibitory potency of leaf extracts compared to stem extracts during the 70-minute recording period. It clearly delineates the temporal patterns of inhibition, highlighting which extracts maintain their inhibitory effects over time and at what concentrations (Figure 2).
Based on the analysis of α-glucosidase inhibition and the respective IC50 values of each P. longifolia extract (Table 1), a clear potency hierarchy emerges: PLLM > PLLE > PLLW > PLSM > PLSE >> PLSW. This order demonstrates that leaf extracts consistently outperform stem extracts, with methanol-based leaf extract (PLLM) exhibiting the highest inhibitory potency. The substantial difference in efficacy between leaf and stem extracts underlines the importance of plant part selection in phytochemical studies. Consequently, for future investigations into α-glucosidase inhibition, these data strongly support prioritizing leaf extracts of P. longifolia, with a particular focus on methanol and ethanol-based preparations due to their higher inhibitory effects.
To further characterize the kinetics of α-glucosidase inhibition obtained with P. longifolia extracts, a graph of the slope of inhibition against logarithmic concentration of the extracts was obtained (Figure 3). This analysis allows for the determination of the Hill coefficient (nH), a parameter that describes the cooperativity in binding between the enzyme and inhibitor, and provides insights on the mechanism of enzyme inhibition [18].
The nH values for the leaf extracts PLLW, PLLE, and PLLM were found to be 2.44, 3.02, and 2.65, respectively (Table 1). These values, being greater than 1, suggest positive cooperativity among the components of each extract in the inhibition of α-glucosidase. This indicates that the binding of inhibitor molecules to the enzyme may enhance the binding of subsequent inhibitor molecules. The steepest Hill slope was observed for PLLE (nH = 3.02), suggesting that the ethanol leaf extract exhibits the highest degree of positive cooperativity among the extracts. This could imply that the constituents in PLLE may interact with multiple sites on the enzyme or induce conformational changes that enhance subsequent inhibitor binding. In contrast, the stem extracts showed minimal to no inhibition, likely due to lower concentrations of active compounds, precluding meaningful Hill plot analysis. The positive cooperativity observed in the leaf extracts, particularly in PLLE and PLLM, may contribute to their potent inhibitory effects on α-glucosidase, as reflected in their low IC50 values.

2.1.2. Albumin Glycation Inhibition

Chronic hyperglycemia and concomitant oxidative stress promote non-enzymatic glycation reactions, leading to the formation of AGEs [19]. These can compromise the functionality of proteins, with albumin being particularly susceptible. In fact, the glycation of albumin is implicated in the pathogenesis of various vascular complications associated with DM, contributing to endothelial dysfunction [20].
To evaluate the antiglycation activity of leaf and stem extracts, the BSA assay was performed. This assay utilizes bovine serum albumin, which shares 76% sequence homology with the human protein, making it a suitable model for studying protein glycation [21]. This assay quantifies the capacity of any substance to inhibit the formation of AGEs between albumin and a reducing sugar, such as ribose [21]. The protocol involved an incubation period of 14 days of 10 mg/mL BSA with 0.05 M ribose. During this period, glycation values increase over time until stabilizing after 12-14 days (Figure S2). Aminoguanidine was used as positive control.
P. longifolia extracts were used at concentrations of 25, 50, 100, 250, and 500 µg/mL, since lower concentrations were not active. It was observed that the aqueous leaf extract (PLLW) does not exhibit any significant activity, whereas both ethanol (PLLE) and methanol (PLLM) extracts, at concentrations of 250 and 500 µg/mL, significantly inhibit BSA glycation (Figure 4). After 7 days of incubation, 500 µg/mL PLLE and PLLM inhibited ribose-induced glycation by 34.05 ± 0.66% and 43.56 ± 2.97%, respectively, showing a slight reduction of AGE formation. The ethanol (PLSE) and methanol (PLSM) stem extracts exhibited significant activity even at a concentration of 100 µg/mL, with inhibition rates of approximately 12% and 16%, respectively. After 7 days of incubation, 500 µg/mL PLSE and PLSM inhibited ribose-induced glycation by 43.34 ± 2.03% and 41.83 ± 3.65%, respectively. Under the experimental conditions, it was observed that the extracts maintain their moderate inhibitory action against albumin glycation throughout the entire 14-day incubation period (data not shown).

2.2. Total Phenol and Flavonoid Contents

Plant-derived phenolic compounds, which include flavonoid compounds, are crucial components of curative plants due to their several health benefits, including antidiabetic effects [22,23]. This study evaluated the presence of these compounds in P. longifolia extracts, characterizing each type of extract using TPC and TFC assays [24]. Figure 5 shows the levels of TPC and TFC, comparing their amount in extracts obtained by use of water, ethanol, and methanol as solvent of extraction (Figure 5A and Figure 5C), and between leaves and stems (Figure 5B and Figure 5D). The methanol leaf extract (PLLM) exhibited the highest phenolic content among all the extracts, Table 2. The relative phenolic content followed the order: PLLM > PLSM ≥ PLLE ≥ PLSE >> PLSW ≥ PLLW. These results demonstrate that methanol is the most appropriate solvent for the extraction of the phenolic compounds of P. longifolia leaves and stems, while water is the least effective, irrespective of the type of tissue (Figure 5). Regarding TFC, flavonoids are present in relatively low quantities, with higher content observed in PLLE and PLLM. Indeed, the TFC/TPC ratios clearly evidences that in these two extracts, the percentage of flavonoids is more relevant compared to the stem extracts and aqueous leaf extract (Table 2). Moreover, the varying TFC/TPC ratios across different extracts indicate that targeted extraction methods could be developed to obtain extracts enriched in specific phenolic subclasses.

2.3. Antiradical Scavenging Activity

It is well known that ROS formation is implicated in the progression of DM complications by several molecular mechanisms, even increasing the formation of AGEs [25,26]. Thus, the use of antioxidants can be considered a preventive intervention to reduce hyperglycemic-related diseases [25,27]. Taking into account the aim to find support for the use of P. longifolia against DM complications, the ORAC assay was conducted. This is a fluorometric assay which quantifies the antioxidant capacity of a substance based on its ability to neutralize peroxyl radicals by donating a hydrogen atom [28]. The results revealed higher antioxidant activity of both ethanol and methanol extracts derived from leaves and stems compared to aqueous extracts (Figure 6). The ethanol stem extract (PLSE) showed a TEAC value of 2130 ± 235 μmol TE/g, similar to that of the methanol stem extract, both significantly higher than all others (Table 2). Particularly, the stem extracts exhibited TEAC/TPC ratios more than twofold higher than those of leaf extracts, indicating that the phenolic compounds obtained from stems are more efficient as antiradical agents.

2.4. HT-29 Viability

The HT-29 cell line, derived from human colorectal adenocarcinoma, exhibits characteristics typical of mature intestinal cells, making it a valuable model for studying the effects of various compounds or plant extracts on intestinal epithelium [29,30]. This study evaluated the influence of leaf and stem P. longifolia extracts tested from 1 to 250 µg/mL on HT-29 cell proliferation (Figure 7). Leaf and stem extracts demonstrated similar effects, while significant differences emerged when comparing aqueous extracts to ethanol or methanol extracts. The latter produced antiproliferative activity at concentrations ≥ 25 µg/mL, causing a concentration-dependent inhibition on cell viability (Figure 7). In contrast, the aqueous extracts (PLLW and PLSW) showed no detectable effect on cell proliferation up to 250 µg/mL (Figure 7). The potency order based on the IC50 values was: PLLM ≥ PLLE > PLSE > PLSM >> PLLW ≥ PLSW (Table 3). The nH provided insights into the concentration-effect relationships: PLLE, PLSE and PLLM have absolute values slightly higher than 1 (from 1.11 to 1.36), indicating a response proximal to a standard interaction between a compound and the target in the cells: one compound molecule, one effect on the cell. PLSM exhibited a more gradual curve (|nH| = 0.76), suggesting a potentially more complex interaction with the cells (Table 3).
These findings suggest a moderate antiproliferative activity of methanol and ethanol P. longifolia extracts on HT-29 cells, with leaf extracts showing higher potency than stem extracts. Aqueous extracts, however, did not influence HT-29 cell proliferation.
Preprints 178906 g007
Figure 7. Effect of the Polyalthia longifolia extracts on HT-29 cell viability after 24 h of incubation. Data are presented as mean ± SEM of 5–6 triplicate experiments. ****: p<0.0001; ***: p<0.001; **: p<0.01; *: p<0.05 vs control (untreated cells). PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract; PLSM: P. longifolia stem methanol extract.
Figure 7. Effect of the Polyalthia longifolia extracts on HT-29 cell viability after 24 h of incubation. Data are presented as mean ± SEM of 5–6 triplicate experiments. ****: p<0.0001; ***: p<0.001; **: p<0.01; *: p<0.05 vs control (untreated cells). PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract; PLSM: P. longifolia stem methanol extract.
Preprints 178906 g007
Table 3. Effects of Polyalthia longifolia leaf and stem extracts on HT-29 cell viability.
Table 3. Effects of Polyalthia longifolia leaf and stem extracts on HT-29 cell viability.
Plant-derived extracts IC50 (95% CI)
µg/mL 		MEC
µg/mL		 nH
PLLW ND ND ND
PLLE 33.24 (25.31-44.08) 50 -1.36
PLLM 24.12 (18.32-32.19) 25 -1.11
PLSW ND ND ND
PLSE 56.71 (43.32-76.33) 50 -1.15
PLSM 72.46 (51.66-108.20) 25 -0.76
IC50: half maximal inhibitory concentration with 95% confidence intervals (CI); MEC: minimum effective concentration, the lowest concentration showing significant inhibition (p < 0.05); nH: Hill slope coefficient. PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract; PLSM: P. longifolia stem methanol extract; ND: not determined. All parameters were obtained using the data from Figure 7.

2.5. Phytochemical Characterization

The composition of P. longifolia leaf and stem extracts was analyzed using HPLC-DAD. Chromatographic profiles revealed that the ethanol and methanol extracts of both leaves and stems exhibited a greater number of peaks with higher intensity compared to their aqueous counterparts (Figure 8). The analysis employed 11 reference compounds for identification: baicalein, caffeic acid, (+)-catechin, chlorogenic acid, ellagic acid, epicatechin, gallic acid, kaempferol, luteolin, quercetin, and rosmarinic acid. These standards permitted the revelation of a diverse phytochemical profile across different solvents and plant parts (Table 4). Among phenolic compounds, gallic acid was exclusively detected in leaf methanol extract (PLLM), while (+)-catechin and epicatechin were found in all alcoholic extracts of both leaves and stems. Caffeic acid was identified in leaf water (PLLW), leaf ethanol (PLLE), and stem water (PLSW) extracts. Ellagic acid was detected across all extracts except the stem water extract (PLSW), with particularly high concentrations observed in PLLE and PLLM. Rosmarinic acid was prominently found in both leaf and stem ethanol extracts (PLLE and PLSE). Among flavonoids, luteolin was detected in low amounts in ethanol and methanol leaf extracts, while baicalein was consistently present across all extracts, regardless of solvent or plant part. These findings underscore the critical influence of the extraction solvent and plant tissue selection on the phytochemical extract profiles. The phenolic compounds observed in this chemical characterization are in agreement with previous reports, supporting the presence of this class of phytoconstituents which may be involved in the beneficial effects of this medicinal plant [31,32,33,34,35].

3. Discussion

Various botanical products are widely proposed for therapy in medicine and as food supplements in many countries for DM management. However, only a fraction of these herbal remedies has undergone rigorous scientific study. This gap underscores the critical need for targeted research in this field. In fact, in vitro and in vivo studies have identified numerous plant-derived products with potential hypoglycemic activity. For example, Momordica charantia L. (bitter melon) and Gymnema sylvestre (Retz.) Schult. have shown promising results [36]. Particularly, Galega officinalis L. led to the discovery of metformin, a cornerstone of antidiabetic treatment [37]. The exploration of traditional medicinal plants, therefore, represents a valuable approach in the search for DM therapy.
In this study, yeast α-glucosidase served as a model assay for screening the potential of P. longifolia extracts as inhibitors of the enzyme activity, potentially helping to reduce glucose absorption from dietary carbohydrates. The leaf extracts exhibited significant concentration-dependent inhibition across all three solvents used for extraction. Specifically, the aqueous extract (PLLW) demonstrated significant inhibitory effects from the concentration of 25 µg/mL, while both ethanol (PLLE) and methanol (PLLM) extracts inhibited at concentrations as low as 5 µg/mL, indicating their higher potency. The respective EC50 values were: 36.87, 10.44, and 7.31 µg/mL (Table 1). Conversely, the stem extracts displayed substantially reduced potency. The aqueous stem extract (PLSW) showed no discernible inhibitory activity, while the ethanol (PLSE) and methanol (PLSM) stem extracts elicited only moderate inhibition at 50 µg/mL and above. Thus, PLLM extract emerged as the most potent inhibitor of α-glucosidase (IC50 = 7.31 µg/mL), exhibiting a positive cooperative interaction with the enzyme, as evidenced by a Hill slope greater than 1, suggesting potential allosteric modulation. Similar effects were shown by the ethanol and aqueous leaf extracts, but with lower potency.
Very few investigations have examined the inhibitory effects of P. longifolia preparations on α-glucosidase and α-amylase activities [12,13]. These studies utilized ethanol and chloroform [12] or methanol and petroleum ether leaf extracts [13], showing that alcohol extracts had superior inhibitory potency, in agreement with current results. Moreover, these extracts exhibited concentration-dependent inhibition of α-glucosidase at concentrations similar to those employed in the present investigation, but with lower potency. Thus, present results not only support the potential of P. longifolia as a source of α-glucosidase inhibitors, but also allow to compare the efficacy of different solvents and tissues used for the extractions. Methanol and ethanol extracts of P. longifolia leaves promote significant concentration-dependent inhibition of α-glucosidase activity. Moreover, the leaf aqueous extract, important also for its traditional use, showed detectable inhibition. To date, no investigations related to the effects of aqueous and ethanol extracts of P. longifolia on α-glucosidase activity have been found in previous literature. Indeed, also few previous in vivo studies have reported the antihyperglycemic effects of P. longifolia extracts. In one study, hyperglycemic rats with blood glucose levels ranging from 250 to 550 mg/dL showed an antihyperglycemic response after a 7-day treatment with methanol leaf extracts (300 mg/kg) [11]. Additionally, in a study using streptozotocin-induced diabetic rats, administration of ethanol and chloroform extracts (100 and 200 mg/kg) caused a significant reduction of fasting blood glucose levels, with effects observed from day 7 to day 28 of treatment [12].
Persistent hyperglycemia and oxidative stress promote non-enzymatic glycation reactions, leading to the formation of AGEs. These processes significantly alter the structures and functions of plasma proteins, particularly serum albumin, which plays a crucial role in the pathogenesis of diabetic vascular complications [19]. In the present study, a ribose-induced BSA glycation assay was employed to evaluate the antiglycation potential of P. longifolia extracts, tested in a concentration range of 25-500 µg/mL. Both leaf and stem extracts demonstrated moderate antiglycation activity, which was sustained throughout the 14-day incubation period. Among the leaf extracts, the aqueous preparation (PLLW) showed no inhibitory activity. In contrast, the ethanol (PLLE) and methanol (PLLM) leaf extracts exhibited comparable glycation inhibition at the higher concentrations, with PLLM achieving a maximum inhibition of 44% while PLLE reached 35%. Interestingly, the stem extracts displayed unexpectedly higher potency; both PLSE and PLSM extracts demonstrated significant antiglycation activity starting from 100 µg/mL, reaching a maximum inhibition of 44% at the higher concentrations. This level of inhibition was comparable to that observed with the leaf extracts, suggesting that P. longifolia stems may be an equally valuable source of antiglycation compounds. Previous studies have reported the antiglycation activity of various flavonoid fractions obtained from P. longifolia leaves using fructose-BSA and methylglyoxal-BSA assays, showing significant inhibition of AGE formation from 5 to 25 mg/mL [34].
Indeed, the TPC and TFC assays revealed a substantial presence of phenols and flavonoids in the P. longifolia extracts. The methanol leaf extract exhibited the highest TPC value (54.74 ± 1.90 mg GAE/g), while the flavonoid content was relatively low in all extracts. In PLLE and PLLM, the flavonoid content was 16.24% and 11.20% lower than the phenol content, respectively. A previous study reported the presence of phenols and flavonoids in methanolic extracts of P. longifolia leaves, with values of TPC = 87.43 ± 1.23 mg GAE/g and TFC = 70.25 ± 3.12 mg catechin equivalent/g [38]. The differences observed could be attributed to different extraction protocols.
In the current investigation, a consistent correlation between phenolic content and extraction solvent was observed for both leaf and stem extracts. Specifically, aqueous extracts (PLLW and PLSW) exhibited lower phenolic content, while methanolic extracts (PLLM and PLSM) exhibited higher levels. This can be explained by the fact that methanol can effectively extract both moderately polar and some less polar compounds, whereas highly polar water will primarily extract highly polar compounds. In general, the higher amount of phenolic and flavonoid compounds in methanol and ethanol extracts suggests that these solvents may be more effective in extracting these bioactive compounds from P. longifolia tissues. This information is valuable for optimizing extraction procedures in future studies and potential therapeutic applications.
Moreover, the significant presence of phenolics and flavonoids in P. longifolia extracts correlates with their antioxidant properties, as quantified by ORAC assay. This analysis revealed consistently higher TEAC values for stem extracts compared to leaf extracts across all the extraction solvents employed. Particularly, the TEAC/TPC ratios were markedly higher for stem extracts (50-67) than for leaf extracts (26-32, Table 2), suggesting that the phenolic compounds in stem extracts have the highest antioxidant capacity. These findings expand previous research, which reported good antiradical activity of a methanol leaf extract using the DPPH assay [38].
In this study, the cytotoxicity of P. longifolia extracts (1 to 250 µg/mL) on HT-29 cell viability was investigated using the MTT assay. The aqueous extracts of both leaves and stems (PLLW and PLSW) showed no significant effects on cell growth. However, the ethanol and methanol extracts caused moderate cytotoxicity at concentrations ≥ 25 µg/mL. The potency order of cell proliferation inhibition based on IC50 values was: PLLM ≥ PLLE > PLSE > PLSM >> PLLW ≥ PLSW. The extracts PLLE, PLSE, and PLLM exhibited absolute nH values slightly higher than 1 (ranging from 1.11 to 1.36), indicating a response proximal to a standard interaction between a compound and its cellular target. Otherwise, PLSM demonstrated a more gradual curve (|nH| = 0.76), suggesting a potentially more complex interaction with the cells. Based on the current results, the aqueous extracts of P. longifolia appear to have a very favorable safety profile, showing no significant cytotoxicity. Differently, the ethanol and methanol extracts had moderate cytotoxicity suggesting they may be used at lower doses. While these in vitro results provide initial insights, comprehensive toxicological studies, including in vivo experiments, are necessary to establish the safety of these extracts for potential phytotherapeutic applications.
Previous phytochemical studies on P. longifolia have identified various constituents, including alkaloids (particularly clerodane diterpenes), terpenoids, steroids (β-sitosterol and stigmasterol) [39,40,41,42], flavonoids [32,33,43], tannins, saponins, phenolic compounds, as gallic acid [33,44,45]. Flavonoids like quercetin, rutin, and chrysin are known for their antioxidant and anti-inflammatory properties, while the isoflavone daidzein exhibits estrogenic and antidiabetic effects [33,43,46]. In the current investigation, HPLC analysis revealed distinct chromatographic profiles for leaf and stem extracts. The aqueous extracts showed fewer constituents, while the ethanol and methanol extracts demonstrated a richer phytochemical composition. The analysis identified various phenolic compounds, and some flavonoids, with distribution varying by solvent and plant part. Gallic acid was exclusive to leaf methanol extract, while (+)-catechin and epicatechin were present in all alcoholic extracts. Caffeic and ellagic acids showed selective distribution, and baicalein was ubiquitous among extracts. The results emphasize the critical influence of extraction methods and plant tissue selection on phytochemical profiles, highlighting the importance of solvent choice in extracting bioactive compounds from P. longifolia. The presence of these phenolic compounds and flavonoids, particularly catechins, epicatechins, and baicalein, may contribute to the observed α-glucosidase inhibition, antiglycation effects, and antioxidant activity of P. longifolia extracts, as these compounds have been previously associated with such beneficial properties [30,47,48].
The comparison between α-glucosidase inhibition and cytotoxicity data reveals that P. longifolia leaf extracts, particularly the methanol (PLLM) and ethanol (PLLE) extracts, show the most promise for potential applications. These extracts demonstrate high α-glucosidase inhibitory activity at concentrations below cytotoxic levels, indicating a favorable therapeutic window. PLLM exhibits the best balance of high inhibitory potency (IC50 = 7.31 µg/mL) and low cytotoxicity (observed at ≥ 25 µg/mL), making it the most promising candidate for further investigation. The aqueous leaf extract (PLLW) shows a good safety profile but lower potency, which might be suitable for applications requiring milder effects and in phytotherapy. In contrast, stem extracts appear less promising due to their lower inhibitory activity occurring at potentially cytotoxic concentrations. These findings suggest that future research should focus on leaf extracts, particularly PLLM and PLLE, to identify specific compounds responsible for the high α-glucosidase inhibitory activity. Additionally, extending these studies to in vivo models could provide valuable insights into the efficacy and safety of these extracts in more complex biological systems, potentially leading to the development of new plant-derived antidiabetic agents.

4. Materials and Methods

4.1. Chemical Reagents

Acarbose, aluminum chloride hexahydrate, aminoguanidine (AG), 2,2′-azobis(2-amidinopropane) dihydrochloride (AAPH), bovine serum albumin (BSA), fluorescein, Folin & Ciocalteu's phenol reagent, gallic acid, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), fetal bovine serum (FBS), α-glucosidase (EC 3.2.1.20, Saccharomyces cerevisiae type I, 10 U/mg protein), 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox), p-nitrophenyl-α-D-glucopyranoside (p-NPG), quercetin, ribose, sodium azide, and sodium carbonate were purchased from Merck Life Science (Milano, Italy). HPLC standards, all other chemicals and solvents were of analytical grade or higher purity (≥ 95% for reference standards, Merck Life Science, Milano, Italy). Purified water was obtained using a Milli-Q water purification system (Millipore, Burlington, MA, USA).

4.2. Plant Extract Preparations

Leaves and stems of P. longifolia var. pendula were collected in June and September 2023 in Yaoundé (Centre Region, Cameroon). The plant material was identified at the National Herbarium of Cameroon by comparison with existing specimens and recorded under the code number 67475HNC.
The leaves and stems were dried at room temperature away from light, then ground into powder. For each extraction, 30 g of powder was used. Three solvents were employed: distilled water, ethanol, and methanol. Each powder sample was macerated in 0.5 L of solvent for 72 h at room temperature. This process was repeated three times to ensure a broad extraction of plant constituents. The resulting mixtures were filtered through Whatman No. 3 filter paper. Alcoholic extracts (methanol and ethanol) were rotary evaporated at 40 °C until complete solvent evaporation. The aqueous extracts were dried in an oven at 40 °C. Successively, the dried extracts were codified as PLLW, PLLE, PLLM (leaf extracts) and PLSW, PLSE, PLSM (stem extracts) for water, ethanol, and methanol, respectively. All extracts were stored at 4°C.
The final yields were as follows: leaf extracts: 6.40% (water), 9.40% (ethanol), and 11.48% (methanol); stem extracts: 1.27% (water), 2.64% (ethanol), and 2.44% (methanol). Samples of the dried extracts from leaves (PLL1-3) and stems (PLS5-7) are deposited at the Department of Pharmaceutical and Pharmacological Sciences, Laboratory of Pharmacognosy, University of Padova (Italy).

4.3. HPLC-DAD Analysis

The chromatographic analysis was performed using a Waters system (Milan, Italy) equipped with a 1525 binary pump and a 2998 photodiode array detector. Separation was achieved on a Symmetry C18 column (4.6 x 75 mm, 3.5 µm, Waters). The mobile phase consisted of (A) 0.1% v/v acetic acid in water, and (B) 0.1% v/v acetic acid in acetonitrile, delivered at 1 mL/min. The gradient elution profile was as follows: 0-1 min: 95% A; 1-7 min: 95-75% A; 7-9 min: 75-60% A; 9-12 min: 60-55% A; 12-14 min: 55-50% A; 14-18 min: 50-40% A; 18-23 min: 40-20% A; 23-28 min: 20-95% A; 28-30 min: 95% A.
P. longifolia ethanol and methanol extracts were dissolved in methanol (2 mg/mL), while P. longifolia water extracts were solubilized in 50:50 water-methanol. The samples were filtered through a 0.22 µm filter before injecting a volume of 20 µL. Chromatograms were recorded from 210-400 nm, with specific analysis at 254 nm (phenolic compounds) and 340 nm (flavonoids). The compound identification was based on retention time and spectral matching with standards.
Eleven reference compounds were used for identification: baicalein, caffeic acid, (+)-catechin, chlorogenic acid, ellagic acid, epicatechin, gallic acid, kaempferol, luteolin, quercetin, and rosmarinic acid. Data acquisition and analysis were performed using Breeze 2 software.

4.4. Yeast α-Glucosidase Inhibition Assay

The α-glucosidase inhibitory activity was assessed using a modified previously reported method [49]. The assay was performed in triplicate in 96-well plates. Each well contained: 80 μL of sample solution or acarbose (positive control at 1.24 mM), 20 μL of α-glucosidase solution (0.5 U/mL). Extracts were tested at concentrations of 1, 5, 10, 25, 50 and 100 µg/mL. After 10 min of incubation at 37 °C, 100 μL of 4 mM p-NPG substrate was added to start the reaction. Enzyme activity was monitored at 405 nm for 70 min using a PerkinElmer Victor Nivo microplate reader (Waltham, MA, USA). Results were expressed as a percentage of the maximum enzyme activity observed without inhibitors.

4.5. BSA Glycation Inhibition Assay

The antiglycation activity of P. longifolia extracts was assessed using a ribose-induced BSA glycation assay [50,51]. BSA (10 mg/mL, pH 7.4) was incubated with 0.05 M ribose at 37 °C for 14 days in the dark, with or without the extracts at concentrations of 25, 50, 100, 250 and 500 µg/mL. Fluorescence intensity, indicative of AGE formation, was measured at excitation/emission wavelengths of 355/460 nm using a PerkinElmer Victor Nivo microplate reader (Waltham, MA, USA). Aminoguanidine (2.5 mM) served as positive control. Readings were taken on days 2, 5, 7, 9, 12, and 14 to monitor the glycation reaction over time. Results were expressed as a percentage of the maximum BSA fluorescence induced by ribose alone.

4.6. TPC and TFC Assays

The TPC assay, a colorimetric test for quantifying phenolic compounds in P. longifolia extracts, was performed using transparent 24-well plates [52]. Gallic acid solutions (25-500 µg/mL) and the extract solutions were prepared. Each well contained 1400 µL deionized water, 100 µL Folin-Ciocalteu reagent, and 20 µL of sample or gallic acid. After 8 min incubation, 300 µL saturated Na2CO3 solution was added to obtain an alkaline environment [53]. After 2 h of incubation at room temperature, absorbance was measured at 760 nm using a PerkinElmer Victor Nivo™ plate reader (Waltham, MA, USA). Total phenolic content was determined using a gallic acid calibration curve and expressed as mg gallic acid equivalents (GAE) per g of dry extract.
The TFC assay was performed in 24-well plates using a quercetin calibration series (6.25-100 µg/mL). Each well contained 250 µL of quercetin standard or the sample extract solution, 1130 µL methanol, and 120 µL AlCl3 (25% w/v). After 15 min incubation at room temperature, absorbance was measured at 410 nm using a PerkinElmer Victor Nivo™ plate reader (Waltham, MA, USA). Blank-subtracted absorbance values were plotted against quercetin concentrations to create a calibration curve. Total flavonoid content was determined by interpolation and expressed as mg quercetin equivalents (QE) per g of extract.

4.7. ORAC Assay

The ORAC assay was used to evaluate the ability of the extracts to counteract the peroxyl radical-induced oxidative reactions [54]. Fluorescein (0.08 µM) was mixed with the sample solutions, PBS (blank), and Trolox (6.25-50 µM, reference standard). Samples were incubated at 37 °C for 10 minutes. The oxidative reaction was initiated by adding 0.15 M AAPH. Fluorescence decay was monitored for 70 min at 37 °C using a PerkinElmer Victor Nivo microplate reader (Waltham, MA, USA). ORAC values were expressed as Trolox Equivalent Antioxidant Capacity (TEAC, µmol TE/g of extract).

4.8. HT-29 Cell Viability Assay

Cell viability was determined using the MTT assay [55]. Human Caucasian colon adenocarcinoma (HT-29) cells were cultured in RPMI 1640 medium supplemented with 10% FBS and maintained in an incubator at 37 °C (5% CO2) until reaching confluence in Petri dishes (Figure S3). Following trypsinization for detachment, the HT-29 cells were seeded in 96-well plates (5,000 cells per well) and allowed to adhere overnight. The cultures were then treated with each P. longifolia extract at 1, 5, 10, 25, 50, 100, and 250 µg/mL, or with medium alone (control). After 24 h, the cells were washed with RPMI 1640 medium and subsequently treated with 0.05 mg/mL MTT for 4 hours. During this period, viable cells reduce the tetrazolium reagent to produce purple formazan crystals, which were then solubilized with 2-propanol (Figure S4). Finally, absorbance was measured using a PerkinElmer Victor Nivo microplate reader (Waltham, MA, USA) at a wavelength of 570 nm. The mean absorbance (Abs) was calculated for each sample concentration and for the controls. The percentage of cell viability in the presence of various sample concentrations was calculated relative to the control.

4.9. Data Analysis and Statistical Methods

Data are presented as mean ± standard error of the mean (SEM) from 3-7 independent experiments. Sigmoid curve fitting and statistical evaluations were performed using GraphPad Prism 10.2.3 (San Diego, CA, USA). The half-maximum inhibitory concentration (IC50), minimum effective concentration (MEC, the lowest concentration showing significant inhibition, p<0.05), and Hill slope coefficient (nH) were calculated by nonlinear regression [18,56,57]. The statistical significance between the control and each treatment was evaluated using the Student's t-test, while comparisons among three or more groups were performed with one-way ANOVA, followed by Tukey's multiple comparison test. Statistical significance was set at p < 0.05.

5. Conclusions

This investigation explored the potential antidiabetic properties of P. longifolia extracts, focusing on leaf and stem preparations using various solvents. Leaf extracts, particularly methanol (PLLM) and ethanol (PLLE) preparations, exhibited significant α-glucosidase inhibition at non-cytotoxic concentrations, with PLLM showing the most promising balance of high inhibitory potency (IC50 = 7.31 µg/mL) and low cytotoxicity. Both leaf and stem extracts displayed moderate antiglycation capacity by inhibiting the formation of AGEs, and antioxidant capacity. The appreciable phenolic and flavonoid content in these extracts correlates with their antidiabetic and antioxidant properties. HPLC analysis identified various phenolic compounds and flavonoids, including catechins, epicatechins, and baicalein, which may contribute to the observed biological activities.
The use of leaves, a renewable resource, coupled with the possibility of domestic cultivation, enhances the cost-effectiveness and sustainability of P. longifolia as a source of new antidiabetic medicines. Future studies should focus on isolating and characterizing specific bioactive compounds, particularly from leaf methanol and ethanol extracts. Furthermore, in vivo studies are necessary to evaluate the efficacy and safety, and clinical trials are crucial next steps to validate the potential therapeutic applications of P. longifolia in diabetes mellitus.

Supplementary Materials

The following supporting information can be downloaded at the website of this paper posted on Preprints.org, Figure S1: Polyalthia longifolia (Sonn.) Thwaites var. pendula (Annonaceae); Figure S2: Kinetics of ribose-induced Advanced Glycation End-products (AGEs) formation.; Figure S3: HT-29 human colon adenocarcinoma cells in culture; Figure S4 HT-29 cell viability assay protocol.

Author Contributions

Conceptualization, G.F.; methodology, M.K.S.; X.G.F.; E.S.; M.L.S.; P.M.J; investigation, L.T.; G.T; F.M.D.; resources, G.F; data curation, L.T.; M.K.S.; G.F.; writing—original draft preparation, G.F.; writing—review and editing, G.F.; funding acquisition, G.F.; FFB. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by MIUR (Ministry of University and Research), Italy.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

Other experimental data are available in the supplementary materials. Additional data are available upon request to authors.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Sun, H.; Saeedi, P.; Karuranga, S.; Pinkepank, M.; Ogurtsova, K.; Duncan, B.B.; Stein, C.; Basit, A.; Chan, J.C.N.; Mbanya, J.C.; et al. IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045. Diabetes Research and Clinical Practice 2022, 183, 109119. [Google Scholar] [CrossRef]
  2. Oyebode, O.; Kandala, N.-B.; Chilton, P.J.; Lilford, R.J. Use of Traditional Medicine in Middle-Income Countries: A WHO-SAGE Study. Health Policy Plan. 2016, 31, 984–991. [Google Scholar] [CrossRef]
  3. Malairajan, P.; Gopalakrishnan, G.; Narasimhan, S.; Veni, Kj.K. Evalution of Anti-Ulcer Activity of Polyalthia Longifolia (Sonn.). Thwaites in Experimental Animals. Indian J Pharmacol 2008, 40, 126. [Google Scholar] [CrossRef] [PubMed]
  4. Firdous, S.M.; Ahmed, S.N.; Hossain, S.M.; Ganguli, S.; Fayed, M.A.A. Polyalthia Longifolia: Phytochemistry, Ethnomedicinal Importance, Nutritive Value, and Pharmacological Activities Review. Med Chem Res 2022, 31, 1252–1264. [Google Scholar] [CrossRef]
  5. Yao, L.J.; Jalil, J.; Attiq, A.; Hui, C.C.; Zakaria, N.A. The Medicinal Uses, Toxicities and Anti-Inflammatory Activity of Polyalthia Species (Annonaceae). Journal of Ethnopharmacology 2019, 229, 303–325. [Google Scholar] [CrossRef] [PubMed]
  6. Katkar, K.V.; Suthar, A.C.; Chauhan, V.S. The Chemistry, Pharmacologic, and Therapeutic Applications of Polyalthia Longifolia. Pharmacogn Rev 2010, 4, 62–68. [Google Scholar] [CrossRef]
  7. Bisht, D.; Prakash, D.; Kumar, R.; Shakya, A.K.; Shrivastava, S. Phytochemical Profiling and Nephroprotective Potential of Ethanolic Leaf Extract of Polyalthia Longifolia against Cisplatin-Induced Oxidative Stress in Rat Model. Journal of Ethnopharmacology 2024, 326, 117922. [Google Scholar] [CrossRef]
  8. Sashidhara, K.V.; Singh, S.P.; Srivastava, A.; Puri, A.; Chhonker, Y.S.; Bhatta, R.S.; Shah, P.; Siddiqi, M.I. Discovery of a New Class of HMG-CoA Reductase Inhibitor from Polyalthia Longifolia as Potential Lipid Lowering Agent. European Journal of Medicinal Chemistry 2011, 46, 5206–5211. [Google Scholar] [CrossRef]
  9. Jothy, S.L.; Yeng, C.; Sasidharan, S. Chromatographic and Spectral Fingerprinting of Polyalthia Longifolia, a Source of Phytochemicals. BioResources 2013, 8, 5102–5119. [Google Scholar] [CrossRef]
  10. Savu, M.; Simo, M.K.; Fopokam, G.X.; Olaru, S.M.; Cioanca, O.; Boyom, F.F.; Stefan, M. New Insights into the Antimicrobial Potential of Polyalthia Longifolia—Antibiofilm Activity and Synergistic Effect in Combination with Penicillin against Staphylococcus Aureus. Microorganisms 2022, 10, 1943. [Google Scholar] [CrossRef]
  11. Nair, R.; Shukla, V.; Chanda, S. Assessment of Polyalthia Longifolia Var. Pendula for Hypoglycemic and Antihyperglycemic Activity. J Clin Diagn Res 2007, 1, 116–121. [Google Scholar]
  12. Sivashanmugam, A.T.; Chatterjee, T.K. In Vitro and in Vivo Antidiabetic Activity of Polyalthia Longifolia (Sonner.). Thw. Leaves. Orient Pharm Exp Med 2013, 13, 289–300. [Google Scholar] [CrossRef]
  13. Brindhadevi, K.; Subramanian, S.A.; Kim, P.T.; Wadaan, M.A.; Selvam, D.R.; Kim, S.J. Antimicrobial and Anti-Diabetic Efficiency of Polyalthia Longifolia Leaf Extracts and Major Compounds Characterization. Environmental Research 2024, 246, 118061. [Google Scholar] [CrossRef] [PubMed]
  14. Khalid, M.; Petroianu, G.; Adem, A. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives. Biomolecules 2022, 12, 542. [Google Scholar] [CrossRef] [PubMed]
  15. Valle-Sánchez, S.L.; Rodríguez-Ramírez, R.; Ávila-Villa, L.A.; Villa-Lerma, A.G.; Davidov-Pardo, G.; Wall-Medrano, A.; González-Córdova, A.F. Natural Inhibitory Compounds of Advanced Glycation End Products (AGEs) from the Maillard Reaction. In Studies in Natural Products Chemistry; Elsevier, 2023; Vol. 79, pp. 341–381. ISBN 978-0-443-18961-6. [Google Scholar]
  16. Zgutka, K.; Tkacz, M.; Tomasiak, P.; Tarnowski, M. A Role for Advanced Glycation End Products in Molecular Ageing. Int J Mol Sci 2023, 24, 9881. [Google Scholar] [CrossRef] [PubMed]
  17. Abbas, G.; Al-Harrasi, A.S.; Hussain, H. α-Glucosidase Enzyme Inhibitors From Natural Products. In Discovery and Development of Antidiabetic Agents from Natural Products; Elsevier, 2017; pp. 251–269. ISBN 978-0-12-809450-1. [Google Scholar]
  18. Goutelle, S.; Maurin, M.; Rougier, F.; Barbaut, X.; Bourguignon, L.; Ducher, M.; Maire, P. The Hill Equation: A Review of Its Capabilities in Pharmacological Modelling. Fundamemntal Clinical Pharma 2008, 22, 633–648. [Google Scholar] [CrossRef]
  19. Zhang, Y.; Zhang, Z.; Tu, C.; Chen, X.; He, R. Advanced Glycation End Products in Disease Development and Potential Interventions. Antioxidants 2025, 14, 492. [Google Scholar] [CrossRef]
  20. Khalid, M.; Petroianu, G.; Adem, A. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives. Biomolecules 2022, 12, 542. [Google Scholar] [CrossRef] [PubMed]
  21. Chen, Y.; Yu, L.; Wang, Y.; Wei, Y.; Xu, Y.; He, T.; He, R. D-Ribose Contributes to the Glycation of Serum Protein. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019, 1865, 2285–2292. [Google Scholar] [CrossRef]
  22. Sun, W.; Shahrajabian, M.H. Therapeutic Potential of Phenolic Compounds in Medicinal Plants—Natural Health Products for Human Health. Molecules 2023, 28, 1845. [Google Scholar] [CrossRef]
  23. Clemente-Suárez, V.J.; Martín-Rodríguez, A.; Beltrán-Velasco, A.I.; Rubio-Zarapuz, A.; Martínez-Guardado, I.; Valcárcel-Martín, R.; Tornero-Aguilera, J.F. Functional and Therapeutic Roles of Plant-Derived Antioxidants in Type 2 Diabetes Mellitus: Mechanisms, Challenges, and Considerations for Special Populations. Antioxidants 2025, 14, 725. [Google Scholar] [CrossRef] [PubMed]
  24. Matić, P.; Sabljić, M.; Jakobek, L. Validation of Spectrophotometric Methods for the Determination of Total Polyphenol and Total Flavonoid Content. Journal of AOAC INTERNATIONAL 2017, 100, 1795–1803. [Google Scholar] [CrossRef]
  25. Giardino, I.; Edelstein, D.; Brownlee, M. BCL-2 Expression or Antioxidants Prevent Hyperglycemia-Induced Formation of Intracellular Advanced Glycation Endproducts in Bovine Endothelial Cells. J. Clin. Invest. 1996, 97, 1422–1428. [Google Scholar] [CrossRef]
  26. Nowotny, K.; Jung, T.; Höhn, A.; Weber, D.; Grune, T. Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus. Biomolecules 2015, 5, 194–222. [Google Scholar] [CrossRef]
  27. Kalogerakou, T.; Antoniadou, M. The Role of Dietary Antioxidants, Food Supplements and Functional Foods for Energy Enhancement in Healthcare Professionals. Antioxidants 2024, 13, 1508. [Google Scholar] [CrossRef] [PubMed]
  28. Munteanu, I.G.; Apetrei, C. Analytical Methods Used in Determining Antioxidant Activity: A Review. IJMS 2021, 22, 3380. [Google Scholar] [CrossRef] [PubMed]
  29. Martínez-Maqueda, D.; Miralles, B.; Recio, I. HT29 Cell Line. In The Impact of Food Bioactives on Health; Verhoeckx, K., Cotter, P., López-Expósito, I., Kleiveland, C., Lea, T., Mackie, A., Requena, T., Swiatecka, D., Wichers, H., Eds.; Springer International Publishing: Cham, 2015; pp. 113–124. ISBN 978-3-319-15791-7. [Google Scholar]
  30. Froldi, G.; Baronchelli, F.; Marin, E.; Grison, M. Antiglycation Activity and HT-29 Cellular Uptake of Aloe-Emodin, Aloin, and Aloe Arborescens Leaf Extracts. Molecules 2019, 24, 2128. [Google Scholar] [CrossRef]
  31. Adaramol, F.B.; Cooposamy, R.M.; Olajuyigbe, O.O. Antimicrobial Activity, Bioactive Constituents, and Functional Groups in Aqueous Methanol Extract of Polyalthia Longifolia (Sonn.). Thwaites Leaves. Pharmacognosy Magazine 2021, 17, 594–604. [Google Scholar] [CrossRef]
  32. Seetharaman, T.R. Flavonoids from the Leaves of Annona Squamosa and Polyalthia Longifolia. Fitoterapia 1986, 57, 198–199. [Google Scholar]
  33. Doshi, G.; Chaskar, P.; Une, H.; Zine, S. Solicitation of HPLC and HPTLC Techniques for Determination of Rutin from Polyalthia Longifolia Thwaites. Phcog Res 2014, 6, 234. [Google Scholar] [CrossRef] [PubMed]
  34. Rai, A.K.; Singh, S.P.; Pandey, A.R.; Ansari, A.; Ahmad, S.; Sashidhara, K.V.; Tamrakar, A.K. Flavonoids from Polyalthia Longifolia Prevents Advanced Glycation End Products Formation and Protein Oxidation Aligned with Fructose-Induced Protein Glycation. Natural Product Research 2021, 35, 2921–2925. [Google Scholar] [CrossRef]
  35. Sashidhara, K.V.; Singh, S.P.; Srivastava, A.; Puri, A. Identification of the Antioxidant Principles of Polyalthia longifolia Var. Pendula Using TEAC Assay. Natural Product Research 2011, 25, 918–926. [Google Scholar] [CrossRef]
  36. Rahman, Md.M.; Islam, Md.R.; Shohag, S.; Hossain, Md.E.; Rahaman, Md.S.; Islam, F.; Ahmed, M.; Mitra, S.; Khandaker, M.U.; Idris, A.M.; et al. The Multifunctional Role of Herbal Products in the Management of Diabetes and Obesity: A Comprehensive Review. Molecules 2022, 27, 1713. [Google Scholar] [CrossRef]
  37. Bailey, C.J. Metformin: Historical Overview. Diabetologia 2017, 60, 1566–1576. [Google Scholar] [CrossRef]
  38. Jothy, S.L.; Aziz, A.; Chen, Y.; Sasidharan, S. Antioxidant Activity and Hepatoprotective Potential of Polyalthia Longifolia and Cassia Spectabilis Leaves against Paracetamol-Induced Liver Injury. Evidence-Based Complementary and Alternative Medicine 2012, 2012, 1–10. [Google Scholar] [CrossRef]
  39. Chang, F.-R.; Hwang, T.-L.; Yang, Y.-L.; Li, C.-E.; Wu, C.-C.; Issa, H.; Hsieh, W.-B.; Wu, Y.-C. Anti-Inflammatory and Cytotoxic Diterpenes from Formosan Polyalthia Longifolia Var. Pendula. Planta Med 2006, 72, 1344–1347. [Google Scholar] [CrossRef]
  40. Chen, C.-Y.; Chang, F.-R.; Shih, Y.-C.; Hsieh, T.-J.; Chia, Y.-C.; Tseng, H.-Y.; Chen, H.-C.; Chen, S.-J.; Hsu, M.-C.; Wu, Y.-C. Cytotoxic Constituents of Polyalthia Longifolia Var. Pendula. J. Nat. Prod. 2000, 63, 1475–1478. [Google Scholar] [CrossRef]
  41. Saleem, R.; Ahmed, M.; Ahmed, S.I.; Azeem, M.; Khan, R.A.; Rasool, N.; Saleem, H.; Noor, F.; Faizi, S. Hypotensive Activity and Toxicology of Constituents from Root Bark ofPolyalthia Longifolia Var. Pendula. Phytother. Res. 2005, 19, 881–884. [Google Scholar] [CrossRef]
  42. Lee, T.-H.; Wang, M.-J.; Chen, P.-Y.; Wu, T.-Y.; Wen, W.-C.; Tsai, F.-Y.; Lee, C.-K. Constituents of Polyalthia Longifolia Var. Pendula. J. Nat. Prod. 2009, 72, 1960–1963. [Google Scholar] [CrossRef]
  43. Sampath M,.; Vasanthi, M. Isolation, Structural Elucidation of Flavonoids from Polyalthia Longifolia (Sonn.) Thawaites and Evaluation of Antibacterial, Antioxidant and Anticancer Potential. International Journal of Pharmacy and Pharmaceutical Sciences 2013, 5, 336–341.
  44. Sampath, M. Isolation and Identification of Gallic Acid from Polyalthia Longifolia (Sonn.) Thawaites. International Journal of Pharma and Bio Sciences 2013, 966–972. [Google Scholar]
  45. Dattatray, T.V.; Baburao, S.P.; Shivaji, C.S. Comprehensive Review on Polyalthia Longifolia. Journal of Traditional Medicine Research 2021, 6, 1–24. [Google Scholar]
  46. Laddha, A.P.; Kulkarni, Y.A. Pharmacokinetics, Pharmacodynamics, Toxicity, and Formulations of Daidzein: An Important Isoflavone. Phytotherapy Research 2023, 37, 2578–2604. [Google Scholar] [CrossRef]
  47. De Araújo, F.F.; De Paulo Farias, D.; Neri-Numa, I.A.; Pastore, G.M. Polyphenols and Their Applications: An Approach in Food Chemistry and Innovation Potential. Food Chemistry 2021, 338, 127535. [Google Scholar] [CrossRef] [PubMed]
  48. Ali Ghasemzadeh Flavonoids and Phenolic Acids: Role and Biochemical Activity in Plants and Human. J. Med. Plants Res. 2011, 5. [CrossRef]
  49. Djeujo, F.M.; Ragazzi, E.; Urettini, M.; Sauro, B.; Cichero, E.; Tonelli, M.; Froldi, G. Magnolol and Luteolin Inhibition of α-Glucosidase Activity: Kinetics and Type of Interaction Detected by In Vitro and In Silico Studies. Pharmaceuticals 2022, 15, 205. [Google Scholar] [CrossRef] [PubMed]
  50. Wei, Y.; Chen, L.; Chen, J.; Ge, L.; He, R.Q. Rapid Glycation with D-Ribose Induces Globular Amyloid-like Aggregations of BSA with High Cytotoxicity to SH-SY5Y Cells. BMC Cell Biol 2009, 10, 10. [Google Scholar] [CrossRef]
  51. Djeujo, F.M.; Francesconi, V.; Gonella, M.; Ragazzi, E.; Tonelli, M.; Froldi, G. Anti-α-Glucosidase and Antiglycation Activities of α-Mangostin and New Xanthenone Derivatives: Enzymatic Kinetics and Mechanistic Insights through In Vitro Studies. Molecules 2022, 27, 547. [Google Scholar] [CrossRef]
  52. Ainsworth, E.A.; Gillespie, K.M. Estimation of Total Phenolic Content and Other Oxidation Substrates in Plant Tissues Using Folin–Ciocalteu Reagent. Nat Protoc 2007, 2, 875–877. [Google Scholar] [CrossRef]
  53. Huang, D.; Ou, B.; Prior, R.L. The Chemistry behind Antioxidant Capacity Assays. J. Agric. Food Chem. 2005, 53, 1841–1856. [Google Scholar] [CrossRef]
  54. Ou, B.; Hampsch-Woodill, M.; Prior, R.L. Development and Validation of an Improved Oxygen Radical Absorbance Capacity Assay Using Fluorescein as the Fluorescent Probe. J. Agric. Food Chem. 2001, 49, 4619–4626. [Google Scholar] [CrossRef] [PubMed]
  55. Van Meerloo, J.; Kaspers, G.J.L.; Cloos, J. Cell Sensitivity Assays: The MTT Assay. In Cancer Cell Culture; Cree, I.A., Ed.; Methods in Molecular Biology; Humana Press: Totowa, NJ, 2011; Vol. 731, pp. 237–245. ISBN 978-1-61779-079-9. [Google Scholar]
  56. Chen, Z.; Bertin, R.; Froldi, G. EC50 Estimation of Antioxidant Activity in DPPH· Assay Using Several Statistical Programs. Food Chem 2013, 138, 414–420. [Google Scholar] [CrossRef] [PubMed]
  57. Morais, P.C.; Silva, D.C. Mathematical Modeling for an MTT Assay in Fluorine-Containing Graphene Quantum Dots. Nanomaterials (Basel) 2022, 12, 413. [Google Scholar] [CrossRef] [PubMed]
Preprints 178906 g001
Figure 1. Effects of aqueous (W), ethanol (E), and methanol (M) extracts obtained from leaves and stems of Polyalthia longifolia, tested at concentrations ranging from 1 to 100 µg/mL, on α-glucosidase activity after 70 min of incubation. AC: acarbose (800 µg/mL, positive control). Data are presented as mean ± SEM of 5 triplicate experiments. *: p < 0.05; **: p < 0.01; ***: p < 0.001; ****: p < 0.0001 vs control (CNT). PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract; PLSM: P. longifolia stem methanol extract.
Figure 1. Effects of aqueous (W), ethanol (E), and methanol (M) extracts obtained from leaves and stems of Polyalthia longifolia, tested at concentrations ranging from 1 to 100 µg/mL, on α-glucosidase activity after 70 min of incubation. AC: acarbose (800 µg/mL, positive control). Data are presented as mean ± SEM of 5 triplicate experiments. *: p < 0.05; **: p < 0.01; ***: p < 0.001; ****: p < 0.0001 vs control (CNT). PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract; PLSM: P. longifolia stem methanol extract.
Preprints 178906 g001
Preprints 178906 g002
Figure 2. Heatmap analysis of α-glucosidase activity inhibited by Polyalthia longifolia extracts over a 70-minute period, in the absence (CNT) and in the presence of leaf and stem extracts, at concentrations from 1 to 100 μg/mL. Color intensity represents enzyme activity levels: red indicates higher enzyme activity, white represents very low activity, while lighter blue shows no activity. The heatmap demonstrates the superior inhibitory potency of leaf extracts compared to stem extracts and allows for comparison of inhibitory effects across different extracts, concentrations, and time points. PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract. PLSM: P. longifolia stem methanol extract.
Figure 2. Heatmap analysis of α-glucosidase activity inhibited by Polyalthia longifolia extracts over a 70-minute period, in the absence (CNT) and in the presence of leaf and stem extracts, at concentrations from 1 to 100 μg/mL. Color intensity represents enzyme activity levels: red indicates higher enzyme activity, white represents very low activity, while lighter blue shows no activity. The heatmap demonstrates the superior inhibitory potency of leaf extracts compared to stem extracts and allows for comparison of inhibitory effects across different extracts, concentrations, and time points. PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract. PLSM: P. longifolia stem methanol extract.
Preprints 178906 g002
Preprints 178906 g003
Figure 3. The slope of inhibition vs the logarithmic concentrations of each extract (Hill plot) allows determination of the Hill coefficient (nH) and provides insights into the cooperativity of enzyme inhibition. PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract; PLSM: P. longifolia stem methanol extract.
Figure 3. The slope of inhibition vs the logarithmic concentrations of each extract (Hill plot) allows determination of the Hill coefficient (nH) and provides insights into the cooperativity of enzyme inhibition. PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract; PLSM: P. longifolia stem methanol extract.
Preprints 178906 g003
Preprints 178906 g004
Figure 4. Effects of aqueous (W), ethanol (E), and methanol (M) extracts obtained from leaves and stems of Polyalthia longifolia, tested at concentrations ranging from 25 to 500 µg/mL, on ribose-induced BSA glycation after 7-day incubation at 37 °C. Data are presented as mean ± SEM of 3 triplicate experiments. *: p < 0.05; ***: p < 0.001; ****: p < 0.0001 vs control (CNT). AG: aminoguanidine (2.5 mM, positive control). PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract; PLSM: P. longifolia stem methanol extract.
Figure 4. Effects of aqueous (W), ethanol (E), and methanol (M) extracts obtained from leaves and stems of Polyalthia longifolia, tested at concentrations ranging from 25 to 500 µg/mL, on ribose-induced BSA glycation after 7-day incubation at 37 °C. Data are presented as mean ± SEM of 3 triplicate experiments. *: p < 0.05; ***: p < 0.001; ****: p < 0.0001 vs control (CNT). AG: aminoguanidine (2.5 mM, positive control). PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract; PLSM: P. longifolia stem methanol extract.
Preprints 178906 g004
Preprints 178906 g005
Figure 5. Phenolic (A and B) and flavonoid (C and D) contents of Polyalthia longifolia extracts. Panels A and C show the total phenolic content (TPC) and total flavonoid content (TFC) grouped by plant tissue type (leaf and stem). Panels B and D show TPC and TFC, grouped by solvent type (water, ethanol, methanol). Data are presented as mean ± SEM of 5–7 duplicate experiments. GAE: gallic acid equivalents; QE: quercetin equivalents. ****: p < 0.0001 vs P. longifolia aqueous extracts (A, C); **: p < 0.01 PLSM vs PLSW (C); ****: p < 0.0001 PLSE vs PLLE (D); **: p < 0.01 PLSM vs PLLM (D). PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract; PLSM: P. longifolia stem methanol extract.
Figure 5. Phenolic (A and B) and flavonoid (C and D) contents of Polyalthia longifolia extracts. Panels A and C show the total phenolic content (TPC) and total flavonoid content (TFC) grouped by plant tissue type (leaf and stem). Panels B and D show TPC and TFC, grouped by solvent type (water, ethanol, methanol). Data are presented as mean ± SEM of 5–7 duplicate experiments. GAE: gallic acid equivalents; QE: quercetin equivalents. ****: p < 0.0001 vs P. longifolia aqueous extracts (A, C); **: p < 0.01 PLSM vs PLSW (C); ****: p < 0.0001 PLSE vs PLLE (D); **: p < 0.01 PLSM vs PLLM (D). PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract; PLSM: P. longifolia stem methanol extract.
Preprints 178906 g005
Preprints 178906 g006
Figure 6. Antiradical activity of aqueous (W), ethanol (E), and methanol (M) extracts obtained from leaves and stems of Polyalthia longifolia determined using the oxygen radical absorbance capacity (ORAC) assay. Panel A shows a comparison based on tissue types, while Panel B compares extraction solvents. PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract; PLSM: P. longifolia stem methanol extract. TEAC: Trolox equivalent antioxidant capacity. Data are presented as mean ± SEM of 3–5 duplicate experiments. ****: p < 0.0001 vs P. longifolia aqueous extracts; **: p < 0.01 vs PLLE; *: p < 0.05 vs PLLM.
Figure 6. Antiradical activity of aqueous (W), ethanol (E), and methanol (M) extracts obtained from leaves and stems of Polyalthia longifolia determined using the oxygen radical absorbance capacity (ORAC) assay. Panel A shows a comparison based on tissue types, while Panel B compares extraction solvents. PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract; PLSM: P. longifolia stem methanol extract. TEAC: Trolox equivalent antioxidant capacity. Data are presented as mean ± SEM of 3–5 duplicate experiments. ****: p < 0.0001 vs P. longifolia aqueous extracts; **: p < 0.01 vs PLLE; *: p < 0.05 vs PLLM.
Preprints 178906 g006
Preprints 178906 g008
Figure 8. HPLC-DAD chromatograms of Polyalthia longifolia extracts. The chromatograms were obtained from the injection of 20 μg/mL of each extract dissolved in methanol, except for the water extracts of leaves and stems, which were solubilized in 50:50 water-methanol. Detection is reported at 254 nm. PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract; PLSM: P. longifolia stem methanol extract.
Figure 8. HPLC-DAD chromatograms of Polyalthia longifolia extracts. The chromatograms were obtained from the injection of 20 μg/mL of each extract dissolved in methanol, except for the water extracts of leaves and stems, which were solubilized in 50:50 water-methanol. Detection is reported at 254 nm. PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract; PLSM: P. longifolia stem methanol extract.
Preprints 178906 g008
Table 1. α-Glucosidase inhibition obtained with P. longifolia leaf and stem extracts.
Table 1. α-Glucosidase inhibition obtained with P. longifolia leaf and stem extracts.
P. longifolia extract α-Glucosidase inhibition
IC50 µg/mL (95% CI)		 α-Glucosidase inhibition
nH		 Primary Effect
PLLW 36.87 (34.72-39.52) 2.44 Weak inhibition
PLLE 10.44 (9.66-11.32) 3.02 Potent inhibition
PLLM 7.31 (6.61-8.21) 2.65 Most potent inhibition
PLSW -- -- No inhibition
PLSE ≥100 -- Very weak inhibition
PLSM ≥100 -- Very weak inhibition
PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract; PLSM: P. longifolia stem methanol extract. IC50: half maximal inhibitory concentration expressed in µg/mL; nH: Hill coefficient, calculated by non-linear regression analysis of concentration-enzyme inhibition (data of Figure 3).
Table 2. Total phenolic and flavonoid contents, and oxygen radical absorbance capacity detected in the leaf and stem Polyalthia longifolia extracts.
Table 2. Total phenolic and flavonoid contents, and oxygen radical absorbance capacity detected in the leaf and stem Polyalthia longifolia extracts.
PLLW PLLE PLLM PLSW PLSE PLSM
TPC
GAE mg/g		 8.57 ± 0.30 38.24 ± 1.88**** 54.74 ± 1.90**** 10.98 ± 0.79 36.65 ± 1.57**** 43.76 ± 2.01****
TFC
QE mg/g 		0.32 ± 0.03 6.21 ± 0.51**** 6.13 ± 0.94**** 0.26 ± 0.03 1.06 ± 0.06 2.81 ± 0.16**
TFC/TPC
(%)		 3.73 16.24 11.20 2.37 2.89 6.42
TEAC
µmol TE /g		 228 ± 22 1242 ± 70*** 1558 ± 144**** 739 ± 121 2130 ± 235**** 2207 ± 256****
TEAC/TPC
µmol TE/mg GAE		 26.60 32.48 28.46 67.30 58.12 50.43
PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract; PLSM: P. longifolia stem methanol extract. TFC/TPC: ratio of total flavonoid content to total phenolic content (expressed as a percentage); TEAC: Trolox equivalent antioxidant capacity; TEAC/TPC: ratio of antioxidant capacity to total phenolic content. Data are presented as mean ± SEM of 3–7 duplicate experiments. ****: p < 0.0001 vs P. longifolia aqueous extracts; ***: p < 0.001 vs PLLW; **: p < 0.01 PLSM vs PLSW.
Table 4. Identification of compounds in Polyalthia longifolia leaf and stem extracts detected by HPLC-DAD.
Table 4. Identification of compounds in Polyalthia longifolia leaf and stem extracts detected by HPLC-DAD.
Compound Class Rt
(min)		 UV-Vis λmax (nm) PLLW PLLE PLLM
Gallic ac. Phenolic ac. 2.537 270 -- -- +
Chlorogenic ac. Phenolic ac. 5.509 322 -- -- --
(+)-Catechin Flavan-3-ol 6.573 280 -- + +
Epicatechin Flavan-3-ol 7.019 278 -- + +
Caffeic ac. Hydroxycinnamic ac. 7.796 325 + + --
Ellagic ac. Phenolic ac. 7.891 256 + +++ ++
Rosmarinic ac. Phenolic ac. 9.521 330 -- ++ --
Luteolin Flavonoid 9.813 348 -- + +
Quercetin Flavonoid 9.981 257; 376 -- -- --
Kaempferol Flavonoid 10.753 265; 364 -- -- --
Baicalein Flavonoid 10.918 277 + + +
Compounds were identified by comparing their retention times (Rt) and UV-Vis spectral profiles with those of authentic standards run under identical conditions. The presence and relative concentration of compounds are indicated as: +++: very high concentration; ++: high concentration; +: present; --: not detected; ac: acid. PLLW: P. longifolia leaf water extract; PLLE: P. longifolia leaf ethanol extract; PLLM: P. longifolia leaf methanol extract; PLSW: P. longifolia stem water extract; PLSE: P. longifolia stem ethanol extract; PLSM: P. longifolia stem methanol extract.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
bsky
MDPI Initiatives
Important Links
Subscribe

© 2026 MDPI (Basel, Switzerland) unless otherwise stated

Accessibility

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings